Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinpocetine in Diabetic Nephropathy
NCT06441591Phase 3Recruiting
- Sponsor
- Ain Shams University
- Start
- Jul 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vinpocetine in diabetic nephropathy (DN), sponsored by Ain Shams University. Started Jul 2024; status: recruiting.
02
Drugs
vinpocetine
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT06441591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06441591.